Mr. Schikan was previously at Genzyme. He is currently Chairman of the boards of Microbiotica and Complix, and board member of Vicore Pharma and VectivBio.
Mr. Schikan is also a member of the Top Team of the Dutch Top Sector Life Sciences & Health. Previously, he served on the boards of Sobi, Hansa Biopharma, Asceneuron, Wilson Therapeutics (acquired by Alexion), Therachon (acquired by Pfizer) and InteRNA. Mr. Schikan has a Pharm.D. degree from Utrecht University.